Birdwatch Archive - Rating Details

Birdwatch Note Rating

2023-08-26 18:56:32 UTC - NOT_HELPFUL

Rated by Participant: 2F369FF8A2D7250B42C8C7502A8AB3D38E1D3C625AEFF3638D886B95C335E2AF
Participant Details

Original Note:

EBC-46 has shown efficacy to reduce cancer in animal studies only. Clinical trials have since commenced for skin, head and neck, and soft tissue cancers in humans. In 2020 the FDA approved an EBC-46–based medication Stelfonta, to treat mast cell cancer in dogs. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/

All Note Details

Original Tweet

All Information

noteId - 1695190002055970932
participantId -
raterParticipantId - 2F369FF8A2D7250B42C8C7502A8AB3D38E1D3C625AEFF3638D886B95C335E2AF
createdAtMillis - 1693076192379
version - 2
agree - 0
disagree - 0
helpful - 0
notHelpful - 0
helpfulnessLevel - NOT_HELPFUL
helpfulOther - 0
helpfulInformative - 0
helpfulClear - 0
helpfulEmpathetic - 0
helpfulGoodSources - 0
helpfulUniqueContext - 0
helpfulAddressesClaim - 0
helpfulImportantContext - 0
helpfulUnbiasedLanguage - 0
notHelpfulOther - 0
notHelpfulIncorrect - 0
notHelpfulSourcesMissingOrUnreliable - 0
notHelpfulOpinionSpeculationOrBias - 0
notHelpfulMissingKeyPoints - 1
notHelpfulOutdated - 0
notHelpfulHardToUnderstand - 0
notHelpfulArgumentativeOrBiased - 0
notHelpfulOffTopic - 0
notHelpfulSpamHarassmentOrAbuse - 0
notHelpfulIrrelevantSources - 0
notHelpfulOpinionSpeculation - 0
notHelpfulNoteNotNeeded - 0
ratingsId - 16951900020559709322F369FF8A2D7250B42C8C7502A8AB3D38E1D3C625AEFF3638D886B95C335E2AF